Overview
CRISPR Therapeutics is a clinical-stage gene editing company developing transformative therapies for serious diseases. Trusted by global research and diagnostic programs.
Key Highlights
- Ex vivo and in vivo CRISPR programs targeting hemoglobinopathies and oncology.
- Partnerships with Vertex, Bayer, and others on cell and gene therapies.
- Manufacturing and regulatory expertise for CRISPR-based medicines.
Ideal For
- Clinicians tracking gene editing therapies entering the market
- Biotech partners exploring CRISPR collaborations
- Investors analyzing the gene editing therapeutic landscape
Quick Links
- Official site: crisprtx.com
- Add to BioDir collections to track updates and collaborators.
